- Lobbying
- Mike AND Jones
Lobbying Arrangements Results for 'Mike Jones'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Policy issues related to Public Law 114-225, the 21st Century Cures Act Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act Policy issues relat... |
Pentec Health, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement issues related to medical technology, including diagnostics. |
SQI Diagnostics
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to outsourcing facilities as defined under Sec. 503B of Public Law No. 113-54, the Drug Quality and Security Act. |
Outsourcing Facilities Association
|
BAKER & HOSTETLER LLP | |||
Details Policy issues regarding healthcare research, including federal funding. |
Southern Research
|
BAKER & HOSTETLER LLP | |||
Details Health care legislation; renewable energy legislation; telecommunications legislation; financial services legislation. |
Ferguson Strategies, LLC
|
in-house lobbying | |||
Details Policy issues relating to digital currencies. |
Ripple Labs, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues relating to Medicare inpatient and outpatient reimbursement, including the New Technology Add-on Payment program. |
Gilead Sciences, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Federal regulatory policy issues related to bioidentical hormone replacement therapy. |
Bioidentical Hormone Replacement Therapy Coalition
|
BAKER & HOSTETLER LLP | |||
Details Issues related to improving patient access for advanced ophthalmic products. |
Eyepoint Pharmaceuticals, Inc.
|
Forbes-Tate | |||
Details Issues related to biopharmaceutical research and innovation. |
Revangenix
|
Forbes-Tate | |||
Details Issues related to primary and specialty care providers and telemedicine. |
Homeward Health
|
Forbes-Tate | |||
Details Issues related to medical education and research. |
Association of American Medical Colleges
|
Forbes-Tate | |||
Details Monitor issues related to Port Everglades expansion. |
Broward County, Florida
|
Capitol Counsel, LLC | |||
Details Foreign Earned Income Exclusion, Section 911 |
MECACC, PREVIOUSLY KNOWN AS AMERICAN BUSINESS COUNCIL OF THE GULF COUNTRIES
|
Capitol Capital Group | |||
Details Issues related to kidney health and Medicare Advantage. |
Healthy.io (US), Inc.
|
Forbes-Tate | |||
Details Issues related to Congressional support for innovation of small technology companies and maintaining pathways antitrust actions by smaller firms. |
AliveCor, Inc.
|
Forbes-Tate | |||
Details Health care reform legislation, including safety and data exclusivity issues regarding follow-on biologics. |
HOFFMANN-LA ROCHE INC.
|
Ferguson Strategies LLC | |||
Details Regulatory and public policy issues regarding Tricare reimbursement. |
AKRIMAX PHARMACEUTICALS, LLC
|
Ferguson Strategies LLC | |||
Details Issues related to the financing of energy projects |
American Municipal Power, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Financial services products, including mortgage-related insurance coverage. |
Venture Quest Capital Partners
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to capital markets and the clearance and settlement of securities transactions. |
Depository Trust & Clearing Corporation
|
BAKER & HOSTETLER LLP | |||
Details S. 1395 Stop Unfair Practices in Credit Cards Act of 2007 H.R. 5244 Stop Unfair Practices in Credit Cards Act of 2007 |
Advanta Corporation
|
Capitol Counsel, LLC | |||
Details Section 301 of the Trade Act of 1974. |
Prime Time Commerce, LLC
|
BAKER & HOSTETLER LLP | |||
Details Tax treatment of U.S. Possessions; H.R. 1908 Patent Reform Act of 2007; S. 1145 Patent Reform Act of 2007 |
Ben Barnes Group
|
Capitol Counsel LLC | |||
Details Tax treatment of Insurance Products; monitor life settlement issues |
Coventry First
|
Capitol Counsel, LLC | |||
Details Telecommunications policy, including as it relates to legislative and regulatory initiatives affecting broadband, video and wireless. |
Verizon Services Corp.
|
Ferguson Strategies LLC | |||
Details HR 3861 - AMT Credit Fairness and Relief Act of 2007 |
Coalition for Tax Fairness
|
Capitol Counsel, LLC | |||
Details Regulatory and public policy issues regarding Tricare reimbursement. |
Triax Pharmaceuticals LLC
|
Ferguson Strategies LLC | |||
Details Federal policy issues related to oil and natural gas production. |
DCOR, LLC
|
BAKER & HOSTETLER LLP | |||
Details H.R. 34, the 21st Century Cures Act H.R. 512, the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act S. 145, the Promise for Antibiotics and Therapeutics for Health Ac... |
The Medicines Company
|
BAKER & HOSTETLER LLP | |||
Details Policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act." Policy and implementation issues relating to Public Law No. 112-144, the "Food... |
Dendreon Corp.
|
Ferguson Strategies, LLC | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Cardinal Health, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues regarding digital currency-based decentralized virtual private network service. |
Orchid Global, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policies that advance market transparency, incentivize capital formation, and ensure a robust secondary market for securities trading, and that affect national securities exchange liability, immuni... |
Equity Markets Association
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Gamida
|
BAKER & HOSTETLER LLP | |||
Details Conservation, management, regulation of fisheries. Conservation and management of menhaden. Reauthorization of the Magnuson-Stevens Fishery Conservation and Management Act. policy related to the Jo... |
Ocean Fleet Services, Inc.
|
Mike Williams Capitol Strategies LLC (f/k/a MW Capitol Strategies LLC) | |||
Details H.R. 6, the "21st Century Cures Act." H.R. 512, the "Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act." S. 145, the "Promise for Antibiotics and Therapeutics for He... |
The Medicines Company
Pharmaceutical manufacturer. |
Ferguson Strategies, LLC | |||
Details H.R. 6, the "21st Century Cures Act." Policy and implementation issues relating to Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections ... |
Pharmaceutical Research and Manufacturers of America
|
Ferguson Strategies, LLC | |||
Details S. 2012, the "Energy Policy Modernization Act." H.R. 8, the "North American Energy Security and Infrastructure Act." Policy issues relating to corporate tax reform, including international tax rules. |
Public Service Enterprise Group
|
Ferguson Strategies, LLC | |||
Details Policy issues related to Public Law 114-225, the 21st Century Cures Act Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act Policy issues relat... |
Prospect Medical Holdings, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Issues related to Securities & Exchange Commission proposals involving capital markets, including equities, fixed income, and derivatives markets (no bill) IRS Oversight |
CITADEL ENTERPRISE AMERICAS SERVICES LLC
|
in-house lobbying | |||
Details Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically related to FDA staffing Policy issues related to Public Law 112-144, the Food and Drug Administration Safety a... |
Portola Pharmaceuticals Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues designed to revitalize the market for small public companies, promote initial public offerings and market transparency, and reduce conflicts of interest in the proxy advisory industry. |
Nasdaq, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically related to combination pharmaceutical products. |
Aralez Pharmaceuticals US, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act, specifically Section 902 related to the Breakthrough Therapy Designation for pharmaceuticals... |
Advaxis, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Prescription Drug User Fee program. Policy and i... |
Eli Lilly and Company
|
Ferguson Strategies, LLC | |||
Details Tax treatment of Insurance Products; monitor life settlement issues |
American Continental Group
|
Capitol Counsel, LLC | |||
Details Specialty pharmacy services for patients Medicare reimbursement for IVIG, including provisions in HR 5597, re: a demonstration project for the furnishing of IVIG in a Medicare patient's home for tr... |
Specialty Pharmacy Coalition
|
Capitol Counsel, LLC | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Biotechnology Innovation Organization
|
BAKER & HOSTETLER LLP | |||
Details Section 301 of the Trade Act of 1974. |
Weber-Stephen Products LLC
|
BAKER & HOSTETLER LLP |